Advisor Group’s Cellectis CLLS Stock Holding History

Advisor Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$282K	Buy	16,477 +2,704	+20%	+$36.1K	﹤0.01%	2118
2019 Q3	$143K	Buy	13,773 +2,122	+18%	+$28.5K	﹤0.01%	2596
2019 Q2	$182K	Buy	11,651 +24	+0.2%	+$429	﹤0.01%	2386
2019 Q1	$213K	Buy	11,627 +491	+4%	+$8.7K	﹤0.01%	2236
2018 Q4	$185K	Buy	11,136 +567	+5%	+$13.1K	﹤0.01%	2146
2018 Q3	$298K	Buy	10,569 +856	+9%	+$24.6K	﹤0.01%	1873
2018 Q2	$275K	Buy	9,713 +155	+2%	+$4.62K	﹤0.01%	1736
2018 Q1	$301K	Buy	9,558 +9,358	+4,679%	+$296K	﹤0.01%	1690
2017 Q4	$6K	Buy	+200	New	+$5.45K	﹤0.01%	4330
2016 Q4	–	Sell	-741	Closed	-$18K	–	4512
2016 Q3	$18K	Buy	+741	New	+$19.4K	﹤0.01%	3209

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Advisor Group's CLLS Position: Q4 2019 in Review

Advisor Group increased its Cellectis (CLLS) stake by 20% in Q4 2019, buying an estimated $36.1K and bringing the position to 16,477 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

Advisor Group first reported a position in CLLS in Q3 2016 and has held it in 10 quarters since. The position peaked at $301K in Q1 2018. 60 funds tracked by Wall St. Rank hold CLLS as of Q4 2019.

Advisor Group held 16,477 shares of Cellectis worth $282K as of Q4 2019.
Advisor Group bought 2,704 Cellectis shares in Q4 2019, an estimated $36.1K.
Cellectis made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2118 holding.
Advisor Group first reported a position in Cellectis in Q3 2016 and has held it in 10 quarters since.
Advisor Group's Cellectis position peaked at $301K in Q1 2018.
60 funds tracked by Wall St. Rank held Cellectis as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.